Aurora Spine reported $17.6 million in revenue during fiscal year 2024, an increase of more than 20% over the previous year.
Here are seven more things to know about the company’s financial report, which was released April 29:
- The company had its largest fourth quarter revenue, bringing in $4.7 million compared to $4.04 million in the fourth quarter of 2023.
- Aurora Spine reported an annual positive EBITDAC in 2024, the first in company history.
- By selling more proprietary products, lower inventory costs and a decrease in commissions to distributors, the company had a 60.5% margin in 2024, a 4% increase over 2023.
- The SiLO-TFX SI joint implant had a revenue growth of 135% in 2024.
- Aurora Spine added to its sales force in 2024, reaching more locations in the U.S. and increasing sales, specifically in the second half of the year.
- The company had operating expenses of $11.45 million in fiscal 2024, including $3.22 million in the fourth quarter.
- Aurora Spine had a net loss of $1 million in fiscal 2024 compared to a net loss of $1.68 million in fiscal 2023.
